Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

24.20
Delayed Data
As of Dec 02
 +0.60 / +2.54%
Today’s Change
16.75
Today|||52-Week Range
44.49
-39.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$895.4M

Company Description

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Contact Information

Lannett Co., Inc.
13200 Townsend Road
Philadelphia Pennsylvania 19154
P:(215) 333-9000
Investor Relations:

Employees

Shareholders

Other institutional55.97%
Individual stakeholders35.86%
Mutual fund holders32.45%

Top Executives

Arthur P. BedrosianChief Executive Officer & Director
Martin P. GalvanCFO, Treasurer & Vice President-Finance
Robert EhlingerChief Information Officer & VP-logistics
Kristie StephensChief Compliance Officer & VP-Regulatory Affairs
John AbtVice President-Quality